- Home
- KMDA vs CLCO Comparison
KMDA vs CLCO Comparison
Compare KMDA & CLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- CLCO
- Stock Information
- Founded
- KMDA 1990
- CLCO 2018
- Country
- KMDA Israel
- CLCO United Kingdom
- Employees
- KMDA N/A
- CLCO N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- CLCO
- Sector
- KMDA Health Care
- CLCO
- Exchange
- KMDA Nasdaq
- CLCO Nasdaq
- Market Cap
- KMDA 430.1M
- CLCO 360.2M
- IPO Year
- KMDA N/A
- CLCO N/A
- Fundamental
- Price
- KMDA $7.35
- CLCO $7.44
- Analyst Decision
- KMDA Strong Buy
- CLCO
- Analyst Count
- KMDA 2
- CLCO 0
- Target Price
- KMDA $13.00
- CLCO N/A
- AVG Volume (30 Days)
- KMDA 49.4K
- CLCO 68.4K
- Earning Date
- KMDA 08-13-2025
- CLCO 08-28-2025
- Dividend Yield
- KMDA 2.72%
- CLCO 8.12%
- EPS Growth
- KMDA 27.97
- CLCO N/A
- EPS
- KMDA 0.32
- CLCO 1.31
- Revenue
- KMDA $169,517,000.00
- CLCO $320,759,000.00
- Revenue This Year
- KMDA $14.51
- CLCO $2.10
- Revenue Next Year
- KMDA $9.31
- CLCO N/A
- P/E Ratio
- KMDA $22.26
- CLCO $5.63
- Revenue Growth
- KMDA 9.67
- CLCO N/A
- 52 Week Low
- KMDA $5.17
- CLCO $4.51
- 52 Week High
- KMDA $9.16
- CLCO $12.41
- Technical
- Relative Strength Index (RSI)
- KMDA 48.99
- CLCO 58.00
- Support Level
- KMDA $7.15
- CLCO $7.01
- Resistance Level
- KMDA $7.85
- CLCO $7.65
- Average True Range (ATR)
- KMDA 0.22
- CLCO 0.28
- MACD
- KMDA 0.00
- CLCO 0.01
- Stochastic Oscillator
- KMDA 54.13
- CLCO 69.57
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About CLCO Cool Company Ltd.
Cool Co Ltd is a LNG shipping company. The company is engaged in the acquisition, ownership, operation and chartering of liquefied natural gas (LNG) carriers (LNGCs), and the operation of third party fleets under management agreements. The company manages its business through a single operating and reporting segment, the LNG carrier market.